Listed

LifeMD, Inc.: Form 10-K for the period ended Dec 31, 2018

Filed with the SEC on Apr 1, 2019 and accepted by EDGAR at Mar 29, 2019, 19:26 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2018-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Cost of revenue12 months2018-01-01 to 2018-12-31$2.0mus-gaap:CostOfRevenue
Gross profit12 months2018-01-01 to 2018-12-31$6.4mus-gaap:GrossProfit
Operating income12 months2018-01-01 to 2018-12-31−$2.1mus-gaap:OperatingIncomeLoss
Interest expense12 months2018-01-01 to 2018-12-31$354.4kus-gaap:InterestExpense
Income tax12 months2018-01-01 to 2018-12-31−$124.7kus-gaap:IncomeTaxExpenseBenefit
Net income12 months2018-01-01 to 2018-12-31−$1.2mus-gaap:NetIncomeLoss
Diluted shares (weighted)12 months2018-01-01 to 2018-12-3144,187,375 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow12 months2018-01-01 to 2018-12-31−$905.5kus-gaap:NetCashProvidedByUsedInOperatingActivities
Cash and equivalentsAt period end2018-12-31$180.1kus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2018-12-31$1.6mus-gaap:AssetsCurrent
Total assetsAt period end2018-12-31$2.6mus-gaap:Assets
Current liabilitiesAt period end2018-12-31$1.2mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2018-12-31$1.8mus-gaap:Liabilities
Shareholders' equityAt period end2018-12-31$897.7kus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001213900-19-005312. Last ingested by Listed: Nov 13, 2026, 16:33 ET. Listed shows no prices and gives no investment advice.